A vibrating pill has shown promise in early studies as a possible obesity treatment. Developed by engineers at MIT (Massachusetts Institute of Technology), the capsule is intended to be swallowed prior to eating in order to “trick” the brain into thinking the body is full — thereby reducing the amount …
Read More »New antibiotic kills deadly, drug-resistant bacteria in ‘scientific breakthrough’
Scientists in Switzerland have announced the discovery of a new class of antibiotics shown to be effective against deadly, drug-resistant bacteria. The antibiotic, called zosurabalpin, works by blocking a bacterial molecule called lipopolysaccharide (LPS), which is responsible for creating the outer membrane that protects a harmful bacteria, Acinetobacter baumannii. Acinetobacter …
Read More »'Next Ozempic' aims to deliver 30% weight loss with fewer side effects
Researchers believe they may have the next, better version of Ozempic in the works. At Tufts University, scientists have developed a new drug that aims to boost weight loss while also reducing the nausea, muscle loss and weight regain associated with popular GLP-1 medications. The goal is for the “quadruple-action” …
Read More »New MRI brain scan predicts Alzheimer's risk years before symptoms develop
Levels of iron in the brain could be a warning sign of future Alzheimer’s disease, a new study suggests. High levels of the chemical element have been shown to increase brain toxins and trigger neurodegeneration, resulting in cognitive decline — especially when they interact with theabnormal amyloid and tau proteins …
Read More »Common vitamin shown to slash skin cancer risk in some groups, study suggests
A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated with the use of nicotinamide, which is a form of vitamin B3. The research examined the health data of …
Read More »New breast cancer drug wins FDA approval after slashing progression risk by nearly 40%
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to treat adults with specific types of the disease. Those types include estrogen receptor-positive (ER+), human epidermal growth factor receptor …
Read More »The hidden reason scientists say bottled water may not be the cleaner choice
Microplastics are a known threat to overall health — and eating and drinking from plastic containers, like water bottles, could be a great offender, researchers suggest. A new study published in the Journal of Hazardous Materials analyzed 141 existing scientific papers on microplastics and nanoplastics from single-use plastic water bottles …
Read More »He carries the Alzheimer’s gene but never got the disease — scientists want to know why
A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School of Medicine in St. Louis recently published a study focusing on Doug Whitney, 76, who lives near Seattle. He …
Read More »Paralyzed man walks again after experimental drug trial triggers remarkable recovery
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital …
Read More »Prostate cancer patients see longer survival with new combination drug
A new treatment strategy tested by UCLA researchers could offer new hope for men whose prostate cancer has returned after initial treatment. This approach could also help delay the need for hormone therapy, which can have burdensome side effects. The findings, which were presented at the annual American Society for …
Read More »